| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |